Your browser doesn't support javascript.
loading
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol.
Gelevski, Dario; Addy, Grace; Rohrer, Margot; Cohen, Caroline; Roderick, Aimee; Winter, Allison; Carey, Judith; Scalia, Jennifer; Yerton, Megan; Weber, Harli; Doyle, Michael; Parikh, Neil; Kane, Geli; Ellrodt, Amy; Burke, Katherine; D'Agostino, Derek; Sinani, Ervin; Yu, Hong; Sherman, Alexander; Agosti, Jan; Redlich, Garry; Charmley, Patrick; Crowe, David; Appleby, Mark; Ziegelaar, Brian; Hanus, Katherine; Li, Zhenhua; Babu, Suma; Nicholson, Katharine; Luppino, Sarah; Berry, James; Baecher-Allan, Clare; Paganoni, Sabrina; Cudkowicz, Merit.
Afiliação
  • Gelevski D; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Addy G; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Rohrer M; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Cohen C; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Roderick A; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Winter A; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Carey J; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Scalia J; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Yerton M; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Weber H; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Doyle M; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Parikh N; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Kane G; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Ellrodt A; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Burke K; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • D'Agostino D; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Sinani E; Implicit Bioscience, Ltd, Brisbane, Australia.
  • Yu H; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Sherman A; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Agosti J; Implicit Bioscience, Ltd, Brisbane, Australia.
  • Redlich G; Implicit Bioscience, Ltd, Brisbane, Australia.
  • Charmley P; Implicit Bioscience, Ltd, Brisbane, Australia.
  • Crowe D; Implicit Bioscience, Ltd, Brisbane, Australia.
  • Appleby M; Implicit Bioscience, Ltd, Brisbane, Australia.
  • Ziegelaar B; Implicit Bioscience, Ltd, Brisbane, Australia.
  • Hanus K; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Li Z; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Babu S; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Nicholson K; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Luppino S; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Berry J; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Baecher-Allan C; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Paganoni S; Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Cudkowicz M; Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Muscle Nerve ; 67(5): 354-362, 2023 05.
Article em En | MEDLINE | ID: mdl-36533976

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article